EP Wealth Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$510K Buy
5,649
+449
+9% +$38.1K ﹤0.01% 1024
2026
Q1
$435K Buy
5,200
+49
+1% +$4.02K ﹤0.01% 968
2025
Q4
$472K Buy
+5,151
New +$493K ﹤0.01% 908
2025
Q2
$541K Sell
5,164
-208
-4% -$19.7K ﹤0.01% 756
2025
Q1
$475K Buy
5,372
+817
+18% +$83.8K ﹤0.01% 724
2024
Q4
$437K Buy
4,555
+403
+10% +$37.6K ﹤0.01% 737
2024
Q3
$340K Buy
+4,152
New +$320K ﹤0.01% 812
2021
Q4
Sell
-7,982
Closed -$517K 553
2021
Q3
$517K Buy
7,982
+3,636
+84% +$253K 0.01% 325
2021
Q2
$350K Buy
4,346
+126
+3% +$9.6K 0.01% 409
2021
Q1
$287K Buy
+4,220
New +$332K 0.01% 410

Other funds holding HQY

EP Wealth Advisors's HQY Position: Q2 2026 in Review

EP Wealth Advisors increased its HealthEquity (HQY) stake by 8.6% in Q2 2026, buying an estimated $38.1K and bringing the position to 5,649 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

EP Wealth Advisors first reported a position in HQY in Q1 2021 and has held it in 10 quarters since. The position peaked at $541K in Q2 2025. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • EP Wealth Advisors held 5,649 shares of HealthEquity worth $510K as of Q2 2026.
  • EP Wealth Advisors bought 449 HealthEquity shares in Q2 2026, an estimated $38.1K.
  • HealthEquity made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #1024 holding.
  • EP Wealth Advisors first reported a position in HealthEquity in Q1 2021 and has held it in 10 quarters since.
  • EP Wealth Advisors's HealthEquity position peaked at $541K in Q2 2025.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.